A few years later, Hogge and coworkers demonstrated the potential of the intradermal delivery of irradiated autologous tumor cells engineered to produce the human GM-CSF in canine melanoma patients after the surgical resection of the tumor [132]. The gene discussed is CSF2; the disease is neoplasm.